FindTrial
Sign In

A medical records based study for the efficacy of integrated Chinese and western medicine in the treatment of acute pancreatitis

The efficacy of integrated Chinese and western medicine in the treatment of acute pancreatitis in the real world

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2000003383
Enrollment
Unknown
Registered
2020-06-06
Start date
2020-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Western medicine treatment group:Western medicine treatment
Integrated traditional Chinese and western medicine treatment group:Integrated traditional Chinese and western medicine treatment

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Meet the diagnostic criteria for AP; 3. Onset to admission within 48 hours.

Exclusion criteria

Exclusion criteria: 1. pregnant or nursing women; 2. Patients with any history of tumor disease; 3. Patients with advanced or terminal stages of any disease.

Design outcomes

Primary

MeasureTime frame
Shortened duration of organ failure in AP patients;—

Secondary

MeasureTime frame
Length of stay in ICU;The incidence of local pancreatic complications;Rate of surgery;the incidence of organ failure;mortality;Infection rate of pancreatic necrosis;treatment cost;The length of stay;—

Countries

China

Contacts

Public ContactQing Xia

West China Hospital, Sichuan University

xiaqing@medmail.com.cn+86 18980601723

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026